Discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS): an early-terminated multicenter randomized controlled trial
Eline Coerver, Wing Hee Fung, Janet de Beukelaar, Willem Bouvy, Leo Canta, O. Gerlach, E. Hoitsma, E. L. J. Hoogervorst, de Jong Brigit,Nynke. F. Kalkers,Zoe van Kempen, Harry Lovenich,Jop Mostert,Caspar van Munster,Bob van Oosten, Joost Smolders,Anke Vennegoor, Esther Zeinstra,Bastiaan Moraal,Frederik Barkhof,Bernard Uitdehaag,Joep Killestein,Eva Strijbis MULTIPLE SCLEROSIS JOURNAL（2023）
AI 理解论文
溯源树
样例
